News

Our Healthcare News

Pierre Fabre Pharmaceuticals and Grupo Biotoscana enter into a Commercialization Agreement

Castres (France) and Montevideo (Uruguay) – July 25, 2016 – Pierre Fabre Pharmaceuticals, the second-largest French private pharmaceutical laboratory and Grupo Biotoscana SL (GBT), a…  

Jul 25 2016

Entellus Medical Announces Presentation of Positive Clinical Results in Pediatric Patients

PLYMOUTH, MN and CHICAGO, IL—Entellus Medical, Inc. (NASDAQ: ENTL) announced today that Dr. Zachary M. Soler, MD, MSc, Medical University of South Carolina, presented the…  

May 19 2016

Endologix Announces CE Mark for Next-Generation Nellix(R) EndoVascular Aneurysm Sealing System

IRVINE, California (GLOBE NEWSWIRE)—Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today achievement of CE (Conformite Europeenne) Mark of the…  

Apr 11 2016

ABIOMED Impella Therapy Receives FDA Approval for Cardiogenic Shock After Heart Attack/Heart Surgery

DANVERS, Massachusetts – April 7, 2016 – Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that it has received…  

Apr 07 2016

AxoGen, Inc. Launches AcroVal Neurosensory and Motor Testing System

ALACHUA, Florida - AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the commercial release…  

Mar 30 2016

FDA Approves Cinqair to Treat Severe Asthma

FRAZER, Pennsylvania—The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in…  

Mar 23 2016

Elusys Therapeutics’ Anthrax Drug Gains FDA Approval in Adults and Children

PINE BROOK, New Jersey—Elusys Therapeutics Inc.’s injectable anthrax antitoxin, branded Anthim (obiltoxaximab), became the newest member of the elite club of drugs to gain FDA…  

Mar 21 2016

Endologix Announces First Patients in Japan Treated with Nellix(R) EndoVascular Aneurysm System

IRVINE, California (GLOBE NEWSWIRE)—Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that the first two patients with abdominal aortic…  

Mar 08 2016

Molecular Partners Reveals Programs in Immuno-Oncology

Zurich-Schlieren, SWITZERLAND— Molecular Partners AG (ticker: MOLN), a clinical-stage biopharmaceutical company that is developing a powerful new class of therapies known as DARPins, today announced…  

Mar 07 2016